More than 80 billion neurons, trillions of synapses and almost 6 kilometres of neural pathways: The brain is an anatomical masterpiece; it is our control centre, memory store, coordinator of thoughts and movement – and still puzzles science. In medicine, the focus is on neurodegenerative diseases such as Alzheimer's and Parkinson's, but also on cerebrovascular disorders such as strokes and brain tumours, notably glioblastoma.
Bringing diagnostics and therapy closer together - that is the basic concept behind theranostics. Through further development of its PET/MR scanners, Siemens Healthineers aims to advance this approach. Andreas Schneck, Head of the MRI Division at Siemens Healthineers, talks about the new system, which was also presented at the European Congress of Radiology (ECR) in Vienna, and its advantages in…
Using an advanced PET scanner, US radiologists explore how cancer, neurodegenerative diseases and other systemic conditions, can affect the brain by assessing the impact on the blood-brain barrier.
Researchers have succeeded in mapping how blood vessels in the brain react after a stroke. This new insight can lead to more effective treatment and fewer complications for patients.
A new AI tool can extract key information from brain MRI scans of multiple sclerosis (MS) patients. This could be used to improve disease and treatment response monitoring.
New research has revealed how Duchenne muscular dystrophy (DMD) also profoundly affects the brain, leading to cognitive and behavioural challenges that are very diverse and some could be reversible.
Using the COX-2 enzyme, a new PET imaging approach offers a never-before-seen view of inflammation in the brain, opening the door for clinical and research settings for various brain disorders.
Using ‘parallel transmit’ technique, researchers have found a new way to detect lesions in the brain of patients with treatment-resistant epilepsy in an MRI scan, without imaging signal dropouts.
Electrodes implanted directly onto the brain’s visual cortex could eventually restore a rudimentary form of vision to people suffering from blindness worldwide, new research suggests.
A novel sensor placed on a patient’s head registers nanometric expansions of the skull in each cardiac cycle in real time to measure intracranial pressure more accurately and non-invasively.
Researchers developed a new scanning method that combines light and ultrasound to non-invasively monitor cerebrovascular changes in the early stages of an ischemic stroke in real time.
Researchers developed an AI-based system which has has a broad ability to identify even subtle differences between medical images taken at different times, and to predict related outcome measures.
Molecular changes associated with brain inflammation and dementia can be detected in the blood. Researchers want to use this to establish blood tests as an alternative to more costly brain scans.
Using a new technology and computational method, researchers have uncovered a biomarker capable of accurately predicting the aggressiveness of meningioma brain tumors and breast cancers.
Traumatic brain injury (TBI) increases dementia risk, but the reasons are poorly understood. Now, a study explores the role of the brain's blood vessels as drivers of Alzheimer's disease.
While thrombectomy to remove blood clots after a stroke is increasingly performed, new research suggests that it may not be needed in all cases.
Research suggests a new approach to detecting Alzheimer’s disease: changes in brain oxygenation dynamics and neuronal function contribute to the neurodegeneration.
Researchers explore the connection between the gut and the brain and its impact on the onset of psychiatric and neurological disorders, including Alzheimer’s.
A new blood test that detects a specific brain protein may help doctors determine the type of a stroke faster and allow them to start safe treatment for people before they get to the hospital.
“A turning point in neuroscience,” say developers about a holographic endoscope that peers deep into the brain through an optical fiber – minimally invasive and with subcellular resolution.
